Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $17.6300 (4.57%) ($16.1600 - $18.5400) on Mon. Mar. 21, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.01% (three month average) | RSI | 52 | Latest Price | $17.6300(4.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -5.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) IBB(52%) ARKG(50%) IWO(48%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -3.505% in a week (0% probabilities). VIXM(-18%) TLT(-13%) UUP(-9%) UNG(-3%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.505% (StdDev 7.01%) | Hourly BBV | 0 () | Intraday Trend | 5.9% | | | |
|
5 Day Moving Average | $16.16(9.1%) | 10 Day Moving Average | $16.43(7.3%) | 20 Day Moving Average | $16.7(5.57%) | To recent high | -33.2% | To recent low | 25.8% | Market Cap | $1.31b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |